Program Identity

EYE103-101

Exact source-linked program identifier and related public trial registrations.

EyeBiotech Ltd.

EYE103-101

1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.

Source records

Linked trial registrations

CompletedNCT05919693

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

PHASE1 · PHASE2 · 33 planned enrolment

Countries listed: 4
Registry update: September 29, 2026

Verify in the registry →